Details for New Drug Application (NDA): 022100
✉ Email this page to a colleague
NDA 022100 describes AZOR, which is a drug marketed by Cosette and is included in one NDA. Additional details are available on the AZOR profile page.
The generic ingredient in AZOR is amlodipine besylate; olmesartan medoxomil. There are fifty drug master file entries for this compound. Additional details are available on the amlodipine besylate; olmesartan medoxomil profile page.
The generic ingredient in AZOR is amlodipine besylate; olmesartan medoxomil. There are fifty drug master file entries for this compound. Additional details are available on the amlodipine besylate; olmesartan medoxomil profile page.
Summary for 022100
| Tradename: | AZOR |
| Applicant: | Cosette |
| Ingredient: | amlodipine besylate; olmesartan medoxomil |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE;20MG | ||||
| Approval Date: | Sep 26, 2007 | TE: | AB | RLD: | Yes | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE;40MG | ||||
| Approval Date: | Sep 26, 2007 | TE: | AB | RLD: | Yes | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE;20MG | ||||
| Approval Date: | Sep 26, 2007 | TE: | AB | RLD: | Yes | ||||
Complete Access Available with Subscription
